Lemaitre Vascular Inc
LMAT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001158895
No open-market purchases or sales by Lemaitre Vascular Inc insiders were filed in the last 90 days; 327 institutions reported holding it in 13F filings for Q2 2026, worth $2.20B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Lemaitre Vascular Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Lemaitre Vascular Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Roberts David B | President and Director | 14,667 | Sep 8, 2026 | 11 |
| Pellegrino Joseph P JR | Director | 15,021 | Sep 8, 2026 | 10 |
| Jasinski Lawrence J | Director | 4,714 | Sep 8, 2026 | 9 |
| Shadan Martha | Director | 2,962 | Sep 8, 2026 | 8 |
| O'Connor John James | Director | 62,827 | Sep 8, 2026 | 9 |
| LeBlanc Dorian Paul | Chief Financial Officer | 2,302 | Sep 8, 2026 | 6 |
| LeMaitre George W | Chairman and CEO | 45,374Indirect | Sep 8, 2026 | 11 |
| Kamke Trent G | Senior V. P., Operations | 3,749 | Sep 8, 2026 | 12 |
| Roush John A | Director | 7,386 | Sep 8, 2026 | 9 |
| Ross Bridget A | Director | 3,942 | May 11, 2026 | 7 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 (view filing) | Aug 11-15 | 4 days | LeMaitre George WChairman and CEO | SSale | −58.6K | $55.17 | −$3.23M | −2.3%2.51M after | 3 lots |
| Aug 11, 2022 (view filing) | Aug 9-10 | 2 days | Pellegrino Joseph P JRChief Financial Officer | SSale | −34.7K | $54.26 | −$1.88M | −85.0%6.11K after | 7 lots |
| Mar 28, 2022 (view filing) | Aug 26, 2020 | 579 daysLate | Roush John ADirector | PPurchase | +30 | $31.06 | +$931.8 | +19.9%181 after | |
| Mar 28, 2022 (view filing) | May 21, 2020 | 676 daysLate | Roush John ADirector | PPurchase | +151 | $25.28 | +$3.82K | New position151 after | |
| Mar 4, 2022 (view filing) | Mar 2 | 2 days | Kamke Trent GSenior V. P., Operations | SSale | −7.93K | $48.22 | −$382.3K | −46.4%9.14K after | |
| Dec 29, 2021 (view filing) | Dec 27 | 2 days | Pellegrino Joseph P JRChief Financial Officer | SSale | −807 | $52.00 | −$42.0K | −8.4%8.85K after | 2 lots |
| Nov 4, 2021 (view filing) | Nov 3 | 1 day | Roberts David BPresident and Director | SSale | −19.7K | $52.24 | −$1.03M | −78.1%5.52K after |